Oramed Pharmaceuticals (ORMP) EBITDA Margin Growth (1y) (2017 - 2023)
Oramed Pharmaceuticals (ORMP) EBITDA Margin Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 113,145.00 |
| Mar 31, 2023 | 90,751.00 |
| Nov 30, 2019 | 32,804.00 |
| Aug 31, 2019 | 16,619.00 |
| May 31, 2019 | 13,690.00 |
| Feb 28, 2019 | -2,067.00 |
| Nov 30, 2018 | -24,129.00 |
| Aug 31, 2018 | -4,888.00 |
| May 31, 2018 | -38,558.00 |
| Feb 28, 2018 | 3,567.00 |
| Nov 30, 2017 | -5,402.00 |
| Aug 31, 2017 | 420,719.00 |
| May 31, 2017 | -164,375.00 |
| Feb 28, 2017 | 97,886.00 |